The Discounted Cash Flow (DCF) valuation of Xvivo Perfusion AB (XVIVO.ST) is 28.82 SEK. With the latest stock price at 310.40 SEK, the upside of Xvivo Perfusion AB based on DCF is -90.7%.
Based on the latest price of 310.40 SEK and our DCF valuation, Xvivo Perfusion AB (XVIVO.ST) is a sell. selling XVIVO.ST stocks now will result in a potential gain of 90.7%.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 8.5% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 17.69 - 162.30 | 28.82 |
| Upside | -94.3% - -47.7% | -90.7% |